SBA
AMGN icon

Secrest Blakey & Associates’s Amgen AMGN Stock Holding History

Secrest Blakey & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$194K – 65
2019
Q3 		$194K Buy
+1,000
New +$192K 0.16% 95

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Secrest Blakey & Associates's AMGN Position: Q3 2020 in Review

Secrest Blakey & Associates reduced its Amgen (AMGN) stake by 0.11% in Q3 2020, selling an estimated $743 and leaving 2,718 shares worth $691K. The position accounts for 1.58% of the portfolio, ranked #23.

Secrest Blakey & Associates first reported a position in AMGN in Q1 2018 and has held it in 11 quarters since. The position peaked at $1.25M in Q3 2018. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Secrest Blakey & Associates held 2,718 shares of Amgen worth $691K as of Q3 2020.
  • Secrest Blakey & Associates sold 3 Amgen shares in Q3 2020, an estimated $743.
  • Amgen made up 1.58% of Secrest Blakey & Associates's portfolio in Q3 2020, its #23 holding.
  • Secrest Blakey & Associates first reported a position in Amgen in Q1 2018 and has held it in 11 quarters since.
  • Secrest Blakey & Associates's Amgen position peaked at $1.25M in Q3 2018.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.